Role of MAOI drugs as triggers of manic episodes in bipolar disorders: A case report and a narrative review

INTRODUCTION: Use of Monoamine Oxidase Inhibitors (MAOIs) has experimented an important reduction in recent years, being replaced by other antidepressant drugs (ADs) associated with a better safety profile. Its use has been restricted to instructed professionals treating resistant and atypical depre...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivier Mayorga, L., Ilzarbe, L., Andreu Gracia, H., Bueno Sanya, L., De Juan Viladegut, O., Barrio, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567157/
http://dx.doi.org/10.1192/j.eurpsy.2022.1032

Ejemplares similares

Ejemplares similares